DIA Biosimilars 2013

CROs/Service Providers

LabCorp to acquire Medtox Scientific

Tuesday, June 5, 2012 08:00 AM

Laboratory Corporation of America Holdings has inked a contract to acquire Medtox Scientific, a St. Paul, Minn.-based provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices.

More... »

Cenduit: Now with Patient Reminders

Cromsource acquires Pleiad, expands U.S. coverage

Friday, June 1, 2012 12:27 PM

Cromsource, an international full service CRO, has acquired Pleiad, an international CRO with offices in the Cambridge, Mass., and Stirling, Scotland.

More... »

CRF Health – eCOA Forum

CMO revenue could double in Europe, says Frost & Sullivan

Thursday, May 31, 2012 03:10 PM

New analysis from Frost & Sullivan, "European Pharmaceutical and Biotech Contract Manufacturing Markets," finds that the European pharmaceutical contract manufacturing market earned revenues of $10.02 billion in 2011 and estimates this to reach $20.75 billion in 2018. Over the same period, the European biotech contract manufacturing market is set to expand from $1.21 billion to an estimated $2.67 billion.

More... »

Specialty CRO Agility Clinical is formed

Thursday, May 31, 2012 02:36 PM

David F. Hale, chairman and CEO of Hale BioPharma Ventures, has founded a new CRO, Agility Clinical, in Carlsbad, Calif.

More... »

Bayer and Covance form strategic partnership

Thursday, May 31, 2012 10:52 AM

Bayer HealthCare and Covance, a CRO based in Princeton, N.J., have established a long-term strategic partnership in the area of clinical drug development including R&D services related to phase II-IV clinical studies and central laboratory services.

More... »

Clinilabs opens phase I unit in New Jersey

Tuesday, May 29, 2012 03:25 PM

New York-based Clinilabs, an early phase and specialty CRO, has opened a second phase I unit in southern New Jersey. The 50-bed capacity, 15,000-square-foot Specialty Pharma Phase I Unit features semi-private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy and exam rooms.

More... »

Recipharm secures financing for future growth

Friday, May 25, 2012 11:32 AM

Recipharm, an international pharmaceutical contract development and manufacturing organization, has arranged a five-year $113 million loan facility with Swedbank, one of the largest banks in Sweden.

More... »

PPD names David Simmons chairman and CEO

Thursday, May 24, 2012 01:19 PM

Global CRO Pharmaceutical Product Development (PPD) has named David Simmons chairman and CEO. Simmons, an experienced pharmaceutical industry executive, joins PPD from Pfizer, where he was president and general manager of the emerging markets and established products business units. Simmons joins PPD June 4 and will be based at the company’s headquarters in Wilmington, N.C.

More... »

SGS acquires Vitrology

Wednesday, May 23, 2012 10:29 AM

SGS, a Swiss inspection, verification, testing and certification company, has decided to acquire Vitrology, a biopharmaceutical contract testing organization based in Glasgow, U.K.

More... »

ERT to hold stockholders meeting to approve acquisition by Genstar

Tuesday, May 22, 2012 09:14 AM

eResearchTechnology (ERT), a global technology-driven provider of health outcomes research services, has scheduled a special meeting of its stockholders to be held on June 22, 2012.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs